Coagulation abnormalities and thrombosis in patients with COVID-19
Although most patients with coronavirus disease 2019 (COVID-19) predominantly have a
respiratory tract infection, a proportion of patients progress to a more severe and systemic
disease, characterised by treatment-resistant pyrexia, acute lung injury with acute
respiratory distress syndrome (ARDS), shock, and multiple organ dysfunction, associated
with substantial mortality.
respiratory tract infection, a proportion of patients progress to a more severe and systemic
disease, characterised by treatment-resistant pyrexia, acute lung injury with acute
respiratory distress syndrome (ARDS), shock, and multiple organ dysfunction, associated
with substantial mortality.
Although most patients with coronavirus disease 2019 (COVID-19) predominantly have a respiratory tract infection, a proportion of patients progress to a more severe and systemic disease, characterised by treatment-resistant pyrexia, acute lung injury with acute respiratory distress syndrome (ARDS), shock, and multiple organ dysfunction, associated with substantial mortality.
thelancet.com